Sharekhan

Gufic BioSciences Ltd

Wed 11/06/2025,15:43:9 NSE: GUFICBIO

₹ 372.35 -1.35 (-0.36%)
BUY NOW Buy Gufic BioSciences Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Gufic BioSciences Ltd

Wed 11/06/2025,16:1:0

Gufic BioSciences Ltd

Wed 11/06/2025,15:43:9 | NSE : GUFICBIO

₹ 372.35-1.35 (-0.36%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 374.60

Previous Close

₹ 373.70

Volume

65838

Mkt Cap ( Rs. Cr)

₹3733.83

High

₹ 388.65

Low

₹ 371.30

52 Week High

₹ 504.25

52 Week Low

₹ 298.80

Book Value Per Share

₹ 57.26

Dividend Yield

0.02

Face Value

₹ 1.00

What’s Your Call?

Collective community sentiment on Gufic BioSciences Ltd

Your Vote -

Buy

84.00%

Hold

12.00%

Sell

4.00%

84.00%

25 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

372.35

294

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

294

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Gufic BioSciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Gufic BioSciences Lt - Analysts/Institutional Investor Meet/Con. Call Updates

    2 Jun 2025, 7:26PM Gufic Biosciences Limited has informed the Exchange about Link of Recording

  • Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    2 Jun 2025, 7:22PM Audio Recording of Earnings Conference Call is attached herewith.

  • Gufic BioSciences Lt - Copy of Newspaper Publication

    31 May 2025, 12:20PM Gufic Biosciences Limited has informed the Exchange about Copy of Newspaper Publication

  • Gufic BioSciences Lt - Investor Presentation

    30 May 2025, 9:47PM Gufic Biosciences Limited has informed the Exchange about Investor Presentation

  • Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Investor Presentation

    30 May 2025, 9:45PM Investor Presentation on Audited Financial Results of the Company for the quarter and financial year ended March 31, 2025 is attached herewith

  • Gufic BioSciences Lt - Update-Acquisition/Scheme/Sale/Disposal-XBRL

    30 May 2025, 9:40PM Gufic Biosciences Limited has informed the Exchange regarding Update-Acquisition/Scheme/Sale/Disposal-XBRL

  • Gufic BioSciences Lt - Acquisition-XBRL

    30 May 2025, 9:25PM Gufic Biosciences Limited has informed the Exchange regarding Acquisition

  • Gufic BioSciences Lt - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    30 May 2025, 9:24PM GUFIC BIOSCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer A

  • Gufic BioSciences Lt - Outcome of Board Meeting-XBRL

    30 May 2025, 9:23PM GUFIC BIOSCIENCES LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 30-May-2025 for Dividend

  • Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    30 May 2025, 7:57PM Intimation for acceptance of equity shares of Gufic Prime Private Limited, Subsidiary Company by way of Right Issue is attached herewith.

  • Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Acquisition

    30 May 2025, 7:54PM Intimation for additional investment in the equity share capital of Veira Life FZE and Gufic Ireland Limited is attached herewith.

  • Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Change in Management

    30 May 2025, 7:49PM Intimation for appointment of Cost Auditor and Secretarial Auditor is attached herewith.

  • Gufic BioSciences Lt - Corporate Action-Board approves Dividend

    30 May 2025, 7:41PM Intimation of recommendation of Final Dividend for the Financial Year 2024-25 is attached herewith.

  • Gufic BioSciences Lt - Change in Auditors

    30 May 2025, 7:41PM Gufic Biosciences Limited has informed the Exchange regarding Change in Auditors of the company.

  • Gufic BioSciences Lt - Results - Audited (Standalone And Consolidated) Financial Results For The Quarter And Financial Year E

    30 May 2025, 7:37PM Audited (Standalone and Consolidated) Financial Results for the Quarter and Financial Year ended March 31, 2025 is attached herewith

  • Gufic BioSciences Lt - Acquisition

    30 May 2025, 7:37PM Gufic Biosciences Limited has informed the Exchange about Acquisition

  • Gufic BioSciences Lt Q4 net profit down 60.25% at Rs 7.97 cr

    30 May 2025, 7:36PM The company reported standalone net profit of Rs 7.97 crore for the quarter ended March 31, 2025 as compared to Rs 20.05 crore in the same period last

  • Gufic BioSciences Lt - Outcome of Board Meeting

    30 May 2025, 7:26PM Gufic Biosciences Limited has informed the Exchange regarding Outcome of Board Meeting held on May 30, 2025.

  • Gufic BioSciences Lt - Outcome of Board Meeting

    30 May 2025, 7:16PM Gufic Biosciences Limited has submitted to the Exchange, the Audited (Standalone and Consolidated) financial results for the Quarter and financial yea

  • Gufic BioSciences Lt - Board Meeting Outcome for Meeting Held On Friday, May 30, 2025

    30 May 2025, 7:14PM Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requireme

  • Gufic BioSciences Lt - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    26 May 2025, 1:42PM Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requireme

  • Gufic BioSciences Lt - Analysts/Institutional Investor Meet/Con. Call Updates

    26 May 2025, 1:42PM Gufic Biosciences Limited has informed the Exchange about Schedule of meet

  • Gufic BioSciences Lt - Board Meeting Intimation

    23 May 2025, 5:14PM GUFIC BIOSCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2025 to consider and approve the Yearly Audited Financial

  • Gufic BioSciences Lt - Board Meeting Intimation for Consideration And Approval Of, Inter Alia, Audited Financial Results (Sta

    23 May 2025, 5:06PM Gufic Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider an

  • Gufic BioSciences Lt - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations,

    2 May 2025, 6:52PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Resignation of Cost Auditor is attached h

  • Gufic BioSciences Lt - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent

    2 May 2025, 6:51PM GUFIC BIOSCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer A

  • Gufic BioSciences Lt - Resignation

    2 May 2025, 6:50PM Gufic Biosciences Limited has informed the Exchange regarding Resignation of M/s. Kale & Associates, Cost Accountants as the Cost Auditor of the comp

  • Gufic BioSciences Lt - Disclosure under SEBI Takeover Regulations

    24 Apr 2025, 3:50PM Jayesh Choksi (For and on behalf of Promoter Group/ PACs of the Company) has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of

  • Gufic BioSciences Lt - Updation Of Contact Details Of Registrar And Share Transfer Agent ('RTA') Of The Company

    18 Apr 2025, 4:36PM Intimation for Updation of Contact Details of Registrar and Share Transfer Agent (\RTA\) of the Company is attached herewith.

  • Gufic BioSciences Lt - Updates

    18 Apr 2025, 4:33PM Gufic Biosciences Limited has informed the Exchange regarding updation of Contact Details of Registrar and Share Transfer Agent ( RTA ) of the Company

  • Gufic BioSciences Lt has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    15 Apr 2025, 5:31PM As of March 2025, 72.51% is owned by Indian Promoters and 27.49% by Public. <p align=justify> Top five Promoters holding highest number of shares of G

  • Gufic BioSciences Lt - Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

    14 Apr 2025, 7:04PM Gufic Biosciences Limited has informed the Exchange about Intimation of Appeal filed against Assessment Order passed by the Assessment Unit, Income Ta

  • Gufic BioSciences Lt - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Apr 2025, 11:55AM Gufic Biosciences Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

  • Gufic BioSciences Lt - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Apr 2025, 11:54AM Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025 is attached herewith

  • Gufic BioSciences Lt - Trading Window-XBRL

    27 Mar 2025, 7:19PM Gufic Biosciences Limited has informed the Exchange about Closure of Trading Window

  • Gufic BioSciences Lt - Trading Window

    27 Mar 2025, 7:17PM Gufic Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations

  • Gufic BioSciences Lt - Action(s) taken or orders passed

    19 Mar 2025, 8:34PM Gufic Biosciences Limited has informed the Exchange about Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regu

  • Gufic BioSciences Lt - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations,

    19 Mar 2025, 8:33PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is attached herewith

  • Gufic receives NMPA China nod for Prilocaine API

    19 Jun 2023 , 11:58AM Gufic Biosciences gets NMPA approval for Prilocaine API

  • Gufic BioSciences

    7 Jun 2022 , 10:08AM Gufic Biosciences: Has launched a new drug delivery system - Dual Chamber Bags at affordable price first time in the India markets. The product launch is basis the collaboration with its European partner. The dual chamber bags come with a peelable aluminium foil allowing the storage of unstable drugs which needs reconstitution just before the administration to the patient. With the launch of this product Gufic aims to capture a major share of Rs 3000 cr lyophilized antibacterial market in India and hence is Positive, though we do not have a coverage on the stock.

  • Gufic Bio gets two patent certificates; stk gains

    6 Jun 2017 , 12:58PM Gufic Biosciences rises over 7% to Rs73.75, after receiving two patent certificates from Intellectual Property India
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Gufic BioSciences Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 911.7375 849.595 659.2153 330.3601 225.1873
Liabilities 911.7375 849.595 659.2153 330.3601 225.1873
Equity 10.0278 10.0278 9.6945 9.6945 9.6945
Gross Profit 134.9885 145.8714 134.6513 145.7147 83.9195
Net Profit 69.9328 86.1356 79.7048 95.8401 44.2316
Cash From Operating Activities 122.7777 -7.4571 -26.5872 104.4442 89.0648
NPM(%) 8.53 10.67 11.54 12.3 9.06
Revenue 819.8059 806.6657 690.6208 779.1556 487.6987
Expenses 684.8174 660.7943 555.9695 633.4409 403.7792
ROE(%) 12.17 15 13.88 16.69 7.7

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
0.1 10 0.03 391
18 Sep 2024 0.1 10 0.03 321.05
24 Aug 2022 0.1 10 0.03 243.9
09 Sep 2021 0.1 10 0.03 190.7
03 Nov 2020 0.05 5 0.03 102.1
20 Sep 2019 0.05 5 0.03 59.7
0.05 5 0.03 145.55
28 Aug 2017 0.05 5 0.03 66.25
19 Sep 2016 0.05 5 0.03 41.05
22 Sep 2015 0.05 5 0.03 14.05
18 Sep 2014 0.05 5 0.03 20.9
02 Sep 2013 0.05 5 0.03 5.55
16 Aug 2012 0.05 5 0.03 7.75
16 Sep 2011 0.05 5 0.03 6.05
20 Sep 2010 0.05 5 0.03 6.35
17 Sep 2009 0.05 5 0.03 6.35
11 Dec 2008 0.05 5 0.03 4.45
19 Mar 2008 0.05 5 0.03 9.45
20 Sep 2006 0.16 16 0.03 11.7
22 Sep 2005 0.22 22 0.03 29.75

Peers

Other companies within the same industry or sector that are comparable to Gufic BioSciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 855.40 0.52 28.38 213.16 301.39 0.58
Lotus Eye Hospital and Institute Ltd 72.06 -1.95 205.89 776.74 3.55 0.00
Vaishali Pharma Ltd 12.58 -2.25 209.67 400.36 3.13 0.00
Astec Lifesciences Ltd 808.70 -0.33 0.00 732.40 -687.10 0.00

Company Info

Central Finance Ltd. is a Bombay based company engaged in leasing, bill discounting, loan syndication, merchant banking/advisory services, investments, debt operations, portfolio management scheme, underwriting etc. Central Finance Securities Ltd. is the subsidiary of the company. The company has 100% stake in the subsidiary. 2000 - The Company name of changed to Gufic Biosciences Ltd. 2003 -Forays into vegetables market under the brand 'Gufic seeds'. 2004 -Gufic Biosciences eyes JV in biotech biz 2005 -Gufic Biosciences - Launch of new products 2007 -Gufic Biosciences Ltd has appointed Dr. M C Dhapalapur as Director of the Company on the Board of Directors of the Company with effect from August 01, 2007. 2008 - The Company has set up manufacturing facility for manufacture of Oncology Products. 2012 - The Board of Directors of the Company, inter alia, has recommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2013 -Gufic Biosciences Ltd has irecommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2014 - Ms. Hemal Deasi, Non- Independent Director has been appointed as an Additional Director. -Gufic Biosciences Ltd has recommended a dividend of Re. 0.05 per share on equity share of Rs. 1/- each.

Central Finance Ltd. is a Bombay based company engaged in leasing, bill discounting, loan syndication, merchant banking/advisory services, investments, debt operations, portfolio management scheme, underwriting etc. Central Finance Securities Ltd. is the subsidiary of the company. The company has 100% stake in the subsidiary. 2000 - The Company name of changed to Gufic Biosciences Ltd. 2003 -Forays into vegetables market under the brand 'Gufic seeds'. 2004 -Gufic Biosciences eyes JV in biotech biz 2005 -Gufic Biosciences - Launch of new products 2007 -Gufic Biosciences Ltd has appointed Dr. M C Dhapalapur as Director of the Company on the Board of Directors of the Company with effect from August 01, 2007. 2008 - The Company has set up manufacturing facility for manufacture of Oncology Products. 2012 - The Board of Directors of the Company, inter alia, has recommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2013 -Gufic Biosciences Ltd has irecommended dividend @ 5% per share (i.e. Re. 0.05 per share). 2014 - Ms. Hemal Deasi, Non- Independent Director has been appointed as an Additional Director. -Gufic Biosciences Ltd has recommended a dividend of Re. 0.05 per share on equity share of Rs. 1/- each.

Read More

Parent Organisation

Gufic BioSciences Ltd.

Founded

23/07/1984

Managing Director

Mr.Jayesh P Choksi

NSE Symbol

GUFICBIOEQ

FAQ

The current price of Gufic BioSciences Ltd is ₹ 372.35.

The 52-week high for Gufic BioSciences Ltd is ₹ 388.65 and the 52-week low is ₹ 371.30.

The market capitalization of Gufic BioSciences Ltd is currently ₹ 3733.83. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Gufic BioSciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Gufic BioSciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Gufic BioSciences Ltd shares.

The CEO of Gufic BioSciences Ltd is Mr.Jayesh P Choksi, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT